Nirrin Technologies specializes in enhancing bioprocessing workflows through innovative analytical systems designed to address common challenges in both upstream and downstream biomanufacturing. Their flagship product, the Atlas™, significantly improves the efficiency of bioprocessing by providing rapid, quantitative results for excipients and antibody titer concentrations. This technology boasts a remarkable speed advantage, delivering results 5000 times faster than traditional methods while requiring 100 times less sample volume and costing 10 times less. By identifying analytical blind spots, Atlas™ enables manufacturers to benchmark their processes and proactively mitigate potential issues, ultimately streamlining the production of life-saving medicines.

In addition to the Atlas™, Nirrin Technologies is committed to advancing biomanufacturing through the development of the HPTLS technology platform, which has received significant funding from the NIH. This platform aims to further enhance the efficiency and effectiveness of biomanufacturing processes, making it easier and more cost-effective to produce high-quality medicines. With a team of experienced professionals based in Boston, MA, Nirrin Technologies is dedicated to transforming the bioprocessing landscape, ensuring that the production of critical therapeutics is not only faster but also more accessible.

United States

We are developing an analytical system designed to reveal blind spots throughout your bioprocess by providing confident answers on antibody titers and excipient concentrations in 30 seconds with 1 workflow and 1 system.


Nirrin Technologies

Company Details